Advanced search
Publication Cover
Artificial Cells, Nanomedicine, and Biotechnology
An International Journal
Volume 46, 2018 - Issue 1
Submit an article Journal homepage
2,275
Views
26
CrossRef citations to date
0
Altmetric
Original Articles

Targeted delivery of doxorubicin into tumor cells by nanostructured lipid carriers conjugated to anti-EGFRvIII monoclonal antibody

Saeideh AbdolahpourDepartment of Medical Biochemistry, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran; View further author information
,
Tayebeh ToliyatDepartment of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran; View further author information
,
Kobra OmidfarBiosensor Research Center, Endocrinology and Metabolism Molecular and Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran; View further author information
,
Helmout ModjtahediSchool of Life Science, Faculty of Science, Engineering and Computing, Kingston University, London; View further author information
,
Albert J. WongBrain Tumor Research Laboratories, Program in Cancer Biology, Stanford University Medical Center, Stanford, CA, USA; View further author information
,
Mohammad Javad RasaeeDepartment of Medical Biotechnology, School of Medical Sciences, Tarbiat Modarres University, Tehran, IranView further author information
,
Susan KashanianDepartment of Medical Biochemistry, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran; View further author information
&
Maliheh PaknejadDepartment of Medical Biochemistry, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran; Correspondence[email protected]
View further author information
 show all
Pages 89-94 | Received 05 Sep 2016, Accepted 15 Feb 2017, Published online: 15 Mar 2017

Citations (26)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Yanming Wang, Zhang Chenghao, Zhaoli Wu, Xinran Cui, Jinmei Ren & Jingling Tang. (2023) In vivo and in vitro evaluation of pulmonary administration of itraconazole nanostructured lipid carriers for pulmonary aspergillosis. Drug Development and Industrial Pharmacy 49:2, pages 232-239.
Read now
Jennifer Thayanne Cavalcante de Araújo, Jonatas Lobato Duarte, Leonardo Delello Di Filippo, Victor Hugo Sousa Araújo, Gabriela Corrêa Carvalho & Marlus Chorilli. (2021) Nanosystem functionalization strategies for prostate cancer treatment: a review. Journal of Drug Targeting 29:8, pages 808-821.
Read now
Md. Habban Akhter, Nv Sateesh Madhav & Javed Ahmad. (2018) Epidermal growth factor receptor based active targeting: a paradigm shift towards advance tumor therapy. Artificial Cells, Nanomedicine, and Biotechnology 46:sup2, pages 1188-1198.
Read now
Imran Khan, Ashutosh Bahuguna, Monika Bhardwaj, Tejinder Pal Khaket & Sun Chul Kang. (2018) Carvacrol nanoemulsion evokes cell cycle arrest, apoptosis induction and autophagy inhibition in doxorubicin resistant-A549 cell line. Artificial Cells, Nanomedicine, and Biotechnology 46:sup1, pages 664-675.
Read now
Qiuhua Luo, Mingyan Jiang, Longfa Kou, Ling Zhang, Guyue Li, Qing Yao, Lei Shang & Ying Chen. (2018) Ascorbate-conjugated nanoparticles for promoted oral delivery of therapeutic drugs via sodium-dependent vitamin C transporter 1 (SVCT1). Artificial Cells, Nanomedicine, and Biotechnology 46:sup1, pages 198-208.
Read now

Articles from other publishers (21)

Dennis Makafui Dogbey, Valeria Esperanza Sandoval Torres, Emmanuel Fajemisin, Liyabona Mpondo, Takunda Ngwenya, Olusiji Alex Akinrinmade, Adam W. Perriman & Stefan Barth. (2023) Technological advances in the use of viral and non-viral vectors for delivering genetic and non-genetic cargos for cancer therapy. Drug Delivery and Translational Research.
Crossref
A. Alper Öztürk, Ebru Başaran, Behiye Şenel, Müzeyyen Demirel & Şenay Sarıca. (2023) Synthesis, characterization, antioxidant activity of Quercetin, Rutin and Quercetin-Rutin incorporated β-cyclodextrin inclusion complexes and determination of their activity in NIH-3T3, MDA-MB-231 and A549 cell lines. Journal of Molecular Structure 1282, pages 135169.
Crossref
Alicia Fernandez-Fernandez, Romila Manchanda & Manisha Kumari. (2023) Lipid-engineered nanotherapeutics for cancer management. Frontiers in Pharmacology 14.
Crossref
Farzaneh Sadeghzadeh, Alireza Motavalizadehkakhky, Jamshid Mehrzad, Rahele Zhiani & Masoud Homayouni Tabrizi. (2023) Folic acid conjugated-chitosan modified nanostructured lipid carriers as promising carriers for delivery of Umbelliprenin to cancer cells: In vivo and in vitro. European Polymer Journal 186, pages 111849.
Crossref
Ana Camila Marques, Paulo C. Costa, Sérgia Velho & Maria Helena Amaral. (2023) Lipid Nanoparticles Functionalized with Antibodies for Anticancer Drug Therapy. Pharmaceutics 15:1, pages 216.
Crossref
Ankaj Kumar, Dilip Panwar, Valamla Bhavana, Pradip Thakor, Pankaj Kumar Singh & Neelesh Kumar Mehra. 2023. Nanomaterial-Based Drug Delivery Systems. Nanomaterial-Based Drug Delivery Systems 65 98 .
Jivesh Garg, Khushboo Pathania, Sangeeta Pilkhwal Sah & Sandip V. Pawar. (2022) Nanostructured lipid carriers: a promising drug carrier for targeting brain tumours. Future Journal of Pharmaceutical Sciences 8:1.
Crossref
Na Ying, Xiangde Lin, Meihua Xie & Dongdong Zeng. (2022) Effect of surface ligand modification on the properties of anti-tumor nanocarrier. Colloids and Surfaces B: Biointerfaces 220, pages 112944.
Crossref
Nisar Ahmad, Arfan Ullah, Peng Chu, Wenzhang Tian, Zeyao Tang & Zhaolin Sun. (2022) Doxorubicin induced cardio toxicity through sirtuins mediated mitochondrial disruption. Chemico-Biological Interactions 365, pages 110028.
Crossref
Ignacio Rivero Berti, Tanya Singh, Tugce Boztepe, Ignacio E. Leon, Ashok KUMAR Nadda & Guillermo R. Castro. 2022. Concepts and Design of Materials Nanoarchitectonics. Concepts and Design of Materials Nanoarchitectonics 381 416 .
Qidong Zhou, Weihong Ding, Zhiyu Qian, Quangang Zhu, Chuanyu Sun, Qin Yu, Zongguang Tai & Ke Xu. (2021) Immunotherapy Strategy Targeting Programmed Cell Death Ligand 1 and CD73 with Macrophage-Derived Mimetic Nanovesicles to Treat Bladder Cancer. Molecular Pharmaceutics 18:11, pages 4015-4028.
Crossref
Sibel Emir Diltemiz, Maryam Tavafoghi, Natan Roberto de Barros, Masamitsu Kanada, Jyrki Heinämäki, Christopher Contag, Stephanie K. Seidlits & Nureddin Ashammakhi. (2021) Use of artificial cells as drug carriers. Materials Chemistry Frontiers 5:18, pages 6672-6692.
Crossref
David Arango, Amaury Bittar, Natalia P. Esmeral, Camila Ocasión, Carolina Muñoz-Camargo, Juan C. Cruz, Luis H. Reyes & Natasha I. Bloch. (2021) Understanding the Potential of Genome Editing in Parkinson’s Disease. International Journal of Molecular Sciences 22:17, pages 9241.
Crossref
Neda Eivazi, Reza Rahmani & Maliheh Paknejad. (2020) Specific cellular internalization and pH-responsive behavior of doxorubicin loaded PLGA-PEG nanoparticles targeted with anti EGFRvIII antibody. Life Sciences 261, pages 118361.
Crossref
Mohamed Haider, Shifaa M. Abdin, Leena Kamal & Gorka Orive. (2020) Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: A Review. Pharmaceutics 12:3, pages 288.
Crossref
Katerina Anagnostou, Minas Stylianakis, Sotiris Michaleas & Athanasios Skouras. 2020. Nanomaterials for Clinical Applications. Nanomaterials for Clinical Applications 123 157 .
Anupriya Anand, Abimanyu Sugumaran & Damodharan Narayanasamy. (2019) Brain targeted delivery of anticancer drugs: prospective approach using solid lipid nanoparticles. IET Nanobiotechnology 13:4, pages 353-362.
Crossref
Mehran Alavi & Mehrdad Hamidi. (2019) Passive and active targeting in cancer therapy by liposomes and lipid nanoparticles. Drug Metabolism and Personalized Therapy 34:1.
Crossref
Diana P. Gaspar & António J. Almeida. 2019. Surface Modification of Nanoparticles for Targeted Drug Delivery. Surface Modification of Nanoparticles for Targeted Drug Delivery 73 98 .
Jeong Moon, Le Manh Hung, Tatsuya Unno & Somi Cho. (2018) Nobiletin Enhances Chemosensitivity to Adriamycin through Modulation of the Akt/GSK3β/β–Catenin/MYCN/MRP1 Signaling Pathway in A549 Human Non-Small-Cell Lung Cancer Cells. Nutrients 10:12, pages 1829.
Crossref
Oi Kwan Wong, Thomas-Toan Tran, Wei-Hsien Ho, Meritxell Galindo Casas, Melinda Au, Marjorie Bateman, Kevin C. Lindquist, Arvind Rajpal, David L. Shelton, Pavel Strop & Shu-Hui Liu. (2018) RN765C, a low affinity EGFR antibody drug conjugate with potent anti-tumor activity in preclinical solid tumor models. Oncotarget 9:71, pages 33446-33458.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.